Histologic Features of Liver Injury Associated With SARS-CoV-2 Messenger RNA Vaccines
Moderate to severe active hepatitis is commonly observed in SARS-CoV-2 mRNA vaccine-associated liver injury, and female patients may be more susceptible to injury. Liver injury resolves spontaneously or with steroid treatment. In rare cases, these vaccines may trigger an underlying immune condition.
Authors
- Maria Westerhoff (ORCID: https://orcid.org/0000-0002-3094-0111)
- Deepti Dhall (ORCID: https://orcid.org/0000-0002-9940-2039)
- Brian Vadasz
- David Escobar (ORCID: https://orcid.org/0000-0002-8322-8451)
- Sameer Al Diffalha
- Rebecca C. Obeng (ORCID: https://orcid.org/0000-0001-8624-7108)
- Jennifer Y. Ju (ORCID: https://orcid.org/0000-0002-9078-3832)
- Adam L. Booth (ORCID: https://orcid.org/0000-0002-1231-4117)
- Yue Xue
- Guangyu Yang (ORCID: https://orcid.org/0000-0002-4692-1361)
- Wei Zheng (ORCID: https://orcid.org/0000-0003-3193-2655)
Institutions
- Northwestern University (US)
- Emory University (US)
- University of Alabama (US)
- Washington University in St. Louis (US)
- University of Michigan (US)
- University Hospitals of Cleveland (US)
- University of Alabama at Birmingham (US)
- University Hospitals Cleveland Medical Center (US)
- University School (US)
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Case Western Reserve University (US)
Publication Details
- Journal
- Archives of Pathology & Laboratory Medicine
- Published
- 2024-09-09
- DOI
- https://doi.org/10.5858/arpa.2024-0095-oa
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39